Amgen
Search results
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
- Alzheimer's Disease
Biogen has signed agreements with the National Association...
- Amyotrophic Lateral Sclerosis
Kate was busy planning her wedding when she was diagnosed...
- Lupus
Biogen’s decades of study at the crossroads of neurology and...
- Multiple Sclerosis
Multiple sclerosis (MS) is a complex, heterogeneous, chronic...
- Spinal Muscular Atrophy
SMA, an inherited disease that can have a devastating effect...
- Pipeline
Breaking New Ground With Science. With a strong focus on...
- News Releases
Biogen Announces Positive Topline Results from Study of...
- Alzheimer's Disease
Biogen is a multinational company that develops therapies for neurological diseases. It was founded in 1978 and has acquired several other biotech firms, such as Idec, Conforma, and Syntonix.
Biogen is a leader in developing medicines for neurology, neuropsychiatry, immunology and rare disease. Learn about its history, culture, innovations, social impact and latest news.
Biogen is a biotechnology company that develops medicines for difficult-to-treat diseases. Learn about its pipeline of potential therapies and how to participate in clinical trials.
Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA
Biogen is a global biotechnology company that develops innovative medicines for neurological diseases. Follow its LinkedIn page to see its latest news, events, research, and career opportunities.
Jun 7, 2021 · Biogen's stock surged 38% after the FDA cleared its drug aducanumab, which is marketed as Aduhelm, to slow cognitive decline in people with Alzheimer's. The drug targets beta-amyloid, a compound in the brain, but its effectiveness and safety are controversial and uncertain.
